Global Therapeutic Nuclear Medicines Sales Market Report 2017


Report ID : RNR-199593 Category : Pharma Healthcare Published Date : Mar 2017
Publisher : QYResearch Pages : 106 Format : PDF
In the recent times, the global market for Global therapeutic nuclear medicines sales market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global therapeutic nuclear medicines sales market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global therapeutic nuclear medicines sales market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global therapeutic nuclear medicines sales market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global therapeutic nuclear medicines sales market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global therapeutic nuclear medicines sales market report 2017, including the definition, classification, and industry chain structure of Global therapeutic nuclear medicines sales market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global therapeutic nuclear medicines sales market report 2017.

In this report, the global Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global therapeutic nuclear medicines sales market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global therapeutic nuclear medicines sales market report 2017, implemented in each of the geographical segments. The predominant applications of the Global therapeutic nuclear medicines sales market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global therapeutic nuclear medicines sales market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global therapeutic nuclear medicines sales market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.
Table of Contents

Global Therapeutic Nuclear Medicines Sales Market Report 2017
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines by Product Category
1.2.1 Global Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Beta Emitters Therapeutic Nuclear Medicines
1.2.4 Alpha Emitters Therapeutic Nuclear Medicines
1.2.5 Brachytherapy Therapeutic Nuclear Medicines
1.3 Global Therapeutic Nuclear Medicines Market by Application/End Users
1.3.1 Global Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Global Therapeutic Nuclear Medicines Market by Region
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.3 China Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.4 Europe Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.7 India Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)

2 Global Therapeutic Nuclear Medicines Competition by Players/Suppliers, Type and Application
2.1 Global Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
2.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Therapeutic Nuclear Medicines (Volume and Value) by Type
2.2.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
2.2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
2.3 Global Therapeutic Nuclear Medicines (Volume and Value) by Region
2.3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017)
2.4 Global Therapeutic Nuclear Medicines (Volume) by Application

3 United States Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
3.1 United States Therapeutic Nuclear Medicines Sales and Value (2012-2017)
3.1.1 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.1.2 United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
3.1.3 United States Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
3.2 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
3.3 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
3.4 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

4 China Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
4.1 China Therapeutic Nuclear Medicines Sales and Value (2012-2017)
4.1.1 China Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.1.2 China Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
4.1.3 China Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
4.2 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
4.3 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
4.4 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

5 Europe Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
5.1 Europe Therapeutic Nuclear Medicines Sales and Value (2012-2017)
5.1.1 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.1.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
5.1.3 Europe Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
5.2 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
5.3 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
5.4 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

6 Japan Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
6.1 Japan Therapeutic Nuclear Medicines Sales and Value (2012-2017)
6.1.1 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
6.1.2 Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
6.1.3 Japan Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
6.2 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
6.3 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
6.4 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

7 Southeast Asia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
7.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2012-2017)
7.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
7.2 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
7.3 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
7.4 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

8 India Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
8.1 India Therapeutic Nuclear Medicines Sales and Value (2012-2017)
8.1.1 India Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
8.1.2 India Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
8.1.3 India Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
8.2 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
8.3 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
8.4 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

9 Global Therapeutic Nuclear Medicines Players/Suppliers Profiles and Sales Data
9.1 Cardinal Health
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Mallkrodt Plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 GE Healthcare
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Lantheus Medical Imaging
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Bayer AG
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Bracco Imaging SpA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Eczacibasi-Monrol Nuclear Products
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Nordion
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Advanced Accelerator Applications SA
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 IBA Molecular Imaging
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Therapeutic Nuclear Medicines Maufacturing Cost Analysis
10.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Therapeutic Nuclear Medicines Market Forecast (2017-2022)
14.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2017-2022)
14.2 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
14.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2017-2022)
14.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2017-2022)
14.4 Global Therapeutic Nuclear Medicines Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer